Condition: Psoriatic Arthritis · Spondyloarthritis, Axial · Sponsor: CARE ARTHRITIS LTD.
A Randomized, Placebo-controlled, Multicenter, Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients with Active Psoriatic Arthritis (UP-SPOUT)
This description comes directly from the study's public registry record.
Amanda Carapellucci · 5874009524 · amanda.carapellucci@carearthritis.com
Rana Dadashova · 5874009524 · rana.dadashova@careathritis.com
Always discuss trial participation with your own doctor first.
| University Hospitals Cleveland Medical Center | Cleveland, Ohio, United States | Recruiting |
| Oregon Health and Science University | Portland, Oregon, United States | Recruiting |
| University of Pennsylvania | Philadelphia, Pennsylvania, United States | Recruiting |
| The Ottawa Hospital Research Institute | Ottawa, Ontario, Canada | Recruiting |
| Groupe de Recherche en Maladies Osseuses (G.R.M.O.) Inc. | Québec, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06454188